Interferon Gamma Release Assays (igras) - Neonatal Disorders

Relevant Publications

Interferon-Gamma Release Assay Combined with Renal Indicators to Reduce the False-Negativity of Latent Tuberculosis Infection in End-Stage Renal Disease with Hemodialysis Patients.

Issue Release: 2024

Comparative Evaluation of Diagnostic Performance: Standard E TB Feron ELISA vs QuantiFERON-TB Gold Plus for Latent Tuberculosis Infection Detection in Diverse Risk Groups in Bangladesh.

Issue Release: 2024

SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot.

Issue Release: 2024

Performance of the Roche Elecsys® IGRA SARS-CoV-2 test for the detection and quantification of virus-reactive T cells in COVID-19-vaccinated immunosuppressed patients and healthy subjects.

Issue Release: 2024

Screening of household contacts for TB infection in Cote d\'Ivoire.

Issue Release: 2024

Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM).

Issue Release: 2024

Tuberculosis Immunoreactivity Surveillance in Malawi (Timasamala)-A protocol for a cross-sectional Mycobacterium tuberculosis immunoreactivity survey in Blantyre, Malawi.

Issue Release: 2024

Prevalence and predictors of tuberculosis infection among people living with HIV in a high tuberculosis burden context.

Issue Release: 2023

Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis.

Issue Release: 2023

Evaluation of the mRNA release assay for diagnosis of TB in HIV-infected individuals.

Issue Release: 2023

Comparison of Four T-cell Assays and Two Binding Antibody Assays in SARS-CoV-2 Vaccinees With or Without Omicron Breakthrough Infection.

Issue Release: 2023

Development of lateral flow assays to detect host proteins in cattle for improved diagnosis of bovine tuberculosis.

Issue Release: 2023

Evaluation of SARS-CoV-2-Specific T-Cell Activation with a Rapid On-Chip IGRA.

Issue Release: 2023

Prevalence of Latent Tuberculosis Infection Among Rheumatology Patients and Management Practices in the United Arab Emirates: A Single-Center Retrospective Cohort Study.

Issue Release: 2023

Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection.

Issue Release: 2023

Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers.

Issue Release: 2023

Comparative analysis between STANDARD-E Covi-FERON ELISA with pre-existing IFN-γ release assays and determination of the optimum cutoff value for assessment of T-Cell response to SARS-CoV-2.

Issue Release: 2023

Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children.

Issue Release: 2023

Prevalence of indeterminate tuberculosis interferon-gamma release assays in COVID-19 patients: Systematic review and meta-analysis.

Issue Release: 2023

Use of Interferon Gamma Release Assays in Children <2 Years Old.

Issue Release: 2023

When is a Skin Culture Necessary?

What Are Some Techniques and Tools Recommended by Lactation Consultants?

Can Pediatricians Participate in Webinars and Online Training?

When Should Testing Be Conducted?

Can Home Remedies Be Effective?

How Long Should a Child Wear an Eye Patch?

Why is the Pediatric Microbiome Important?

How to Recognize Mental Health Issues?

Why is Play Important for Child Development?

How Do Hospital Grade Breast Pumps Work?

Interferon Gamma Release Assays (igras) - Neonatal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics